NCT00002470View on ClinicalTrials.gov

Fluorouracil Plus Interferon Alfa in Treating Patients With Advanced Metastatic Carcinoid Tumors

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 1990

Study Completion Date

January 31, 2004

Conditions
Gastrointestinal Carcinoid TumorLung Cancer
Interventions
BIOLOGICAL

recombinant interferon alfa

DRUG

fluorouracil

Trial Locations (1)

20037

George Washington University Medical Center, Washington D.C.

Sponsors
All Listed Sponsors
collaborator

Cancer Biotherapy Research Group

OTHER

lead

Mid-Atlantic Oncology Program

OTHER

NCT00002470 - Fluorouracil Plus Interferon Alfa in Treating Patients With Advanced Metastatic Carcinoid Tumors | Biotech Hunter | Biotech Hunter